Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Ocugen, Inc. (OCGN) on Thursday reported a loss of $13 million in its third quarter. On a per-share basis, the Malvern, Pennsylvania-based company said it had a ...